Amazon's Secretive Foray Into Healthcare. But Will It Disrupt the Industry?

Commentary by Todd Perman, Executive Managing Director, Global Healthcare Services

Tech companies are eyeing the healthcare sector as innovation, like telemedicine and drones, mature and expose big opportunities to disrupt the status quo. We’re already seeing this trend within the industry. While it’s hard to anticipate all of the ways in which technology will impact healthcare, the article illustrates how impactful this trend could be in the near future.

Article written by Praveen Suthrom with NextServices

Every time a big boy enters healthcare, there's nervous excitement in the market.

Google entered with Verily. Apple did with HealthKit. Microsoft's always been there. With Watson, IBM makes big promises of cognitive healthcare applications. Even Facebook, I learn, has healthcare ambitions.

How could possibly Amazon resist?

Amazon's secretive team is called 1492. The year Columbus entered America. Team 1492 supposedly is working on legacy electronic medical records and telemedicine.

Goldman Sachs took the cue and put together a 30-page report. Here are the highlights from the report as reported by CNBC:

Read the full article here


All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter